Dermatology

Network meta-analysis ranks brucellosis treatment regimens, finding triple-drug combinations outperform widely used dual therapies.

Children with moderate-to-severe generalized pustular psoriasis (GPP) benefit significantly from biologic therapy.

Cutaneous venous malformations (cVMs), rare vascular anomalies marked by progressive vessel dilation, pain, ulceration, and bleeding, may be more prevalent in the US than previously recognized.

Helical tomotherapy combined with paclitaxel demonstrated encouraging survival outcomes with manageable toxicity in patients with cutaneous angiosarcoma.

Adalimumab use in patients with hidradenitis suppurativa (HS) appears safe with appropriate prophylaxis, as no cases of hepatitis B virus (HBV) or tuberculosis (TB) reactivation were observed in a large retrospective analysis.

Dupilumab may provide meaningful relief for patients with chronic kidney disease who experience uremic pruritus and for those with atopic dermatitis complicated by renal impairment, according to a retrospective real-world study.

Oral JAK inhibitors appear effective and safe in the treatment of vitiligo, according to a retrospective study evaluating real-world outcomes in nearly 100 patients.

Children under 12 years with moderate to severe atopic dermatitis experienced varying outcomes with systemic therapies, according to new real-world data from the PEDISTAD registry.